Comcast Appeals National Advertising Division Recommendation to Discontinue or Modify Xfinity “10G” Claim

New York, NY – October 12, 2023 – In a challenge brought by Verizon Communications Inc, the National Advertising Division (NAD) of BBB National Programs recommended that Comcast Cable Communications, LLC discontinue the claim “10G” for its Xfinity 10G Network or qualify the claim to make clear that Comcast is implementing improvements that will enable it to achieve 10G and that 10G is aspirational or use “10G” in a manner that is not false or misleading.

In February 2023, Comcast rebranded its fixed internet network as “Xfinity 10G Network” to signify technological upgrades that continue to be implemented. Verizon challenged the name “Xfinity 10G Network” and the claim “10G,” which appeared in a myriad of advertisements online and on television.

NAD concluded that “10G” as used in the name “Xfinity 10G Network” and “Xfinity 10G” is an express claim. 

In evaluating this claim, NAD found that Comcast’s description of its entire network as “10G” conveys the message that all consumers on the network will receive a significant increase in speed up to 10 Gbps. However, NAD determined that the 10 Gbps message was not substantiated because only one of Xfinity’s many plans (Gigabit Pro) can reach 10 Gbps, and access to that service tier requires installation of fiber to the premises. Further, NAD concluded, that to the extent that consumers understand 10G as referring to 10th generation mobile technology, this message is also unsupported.

For these reasons, NAD recommended that Comcast discontinue the claim “10G.”

Alternatively, NAD stated that Comcast may modify the claim by (a) qualifying it to make clear that they are implementing improvements that will enable it to achieve 10G and that 10G is the aspiration, or (b) using it in a manner that is not false or misleading consistent with this decision. 

In its advertiser statement, Comcast stated that it will appeal NAD’s decision because it “disagrees with NAD’s decision, including NAD’s determination that the Xfinity 10G Network brand name constitutes an ‘express claim.’” 

Appeals of NAD decisions are made to the BBB National Programs’ National Advertising Review Board (NARB), the appellate-level truth-in-advertising body of BBB National Programs. 

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product

New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.

Read the Decision Summary
Decision

National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin

New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin. 

Read the Decision Summary
Decision

In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products

New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.” 

Read the Decision Summary
Decision

National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies

New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.

Read the Decision Summary